- Home
- HLXC vs GALT Comparison
HLXC vs GALT Comparison
Compare HLXC & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$3.05
Company Overview
Basic Information| Metric | HLXC | GALT |
|---|---|---|
| Founded | 2025 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.9M | 176.7M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | HLXC | GALT |
|---|---|---|
| Price | $10.17 | $3.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 12.1K | ★ 276.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.13 | $1.15 |
| 52 Week High | $10.35 | $7.13 |
Technical Indicators
Market Signals| Indicator | HLXC | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 48.57 |
| Support Level | $10.14 | $2.88 |
| Resistance Level | $10.31 | $3.27 |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 17.82 | 33.61 |
Price Performance
Historical Comparison HLXC
GALT
About HLXC Helix Acquisition Corp. III Class A Ordinary Shares
Helix Acquisition Corp III is a blank check company.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.